Product Images Pregabalin
View Photos of Packaging, Labels & Appearance
Product Label Images
The following 14 images provide visual information about the product associated with Pregabalin NDC 70518-2978 by Remedyrepack Inc., such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.
Remedy_Label - Remedy Label
Pregabalin is a medication that comes in the form of capsules with a strength of 300 mg. The package contains 60 capsules and has an NDC number of 70518-2978-00. The manufacturer is Amneal Pharma, located in Ahmedabad, India. The medication should be stored at a temperature of 20-26°C (63-77°F), with excursions permitted to 15-30°C (59-86°F) [See USP]. The package insert should be consulted for directions for use, and the medication should be kept out of the reach of children. The lot number and expiration date are not available. The medication has been repackaged by RemedyRepack Inc., located in Indiana, PA 15701.*
10 - pregabalin capsules 1
This appears to be a calculation for estimating creatinine clearance (CLCr) based on age, weight, and serum creatinine level. The formula suggests multiplying the difference between 140 and the patient's age in years by their weight in kilograms, and then dividing that product by 72 times their serum creatinine level in milligrams per deciliter. For female patients, the result should be multiplied by 0.85. This calculation is commonly used in clinical settings to determine kidney function and guide dosing of medications.*
F-8 - pregabalin capsules 10
Fig-9 - pregabalin capsules 11
F-10 - pregabalin capsules 12
F-11 - pregabalin capsules 13
structure - pregabalin capsules 2
F1 - pregabalin capsules 3
F-2 - pregabalin capsules 4
F-3 - pregabalin capsules 5
F-4 - pregabalin capsules 6
F-5 - pregabalin capsules 7
The text is a graph showing the percentage improvement in pain for patients who were given either 100mg of pregabalin three times a day, 50mg of pregabalin three times a day, or a placebo. The graph shows that patients given either dosage of pregabalin had a higher percentage improvement in pain compared to those who were given a placebo. The x-axis shows the time in weeks and the y-axis shows the percentage improvement in pain from baseline.*
F-6 - pregabalin capsules 8
F-7 - pregabalin capsules 9
* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.